A 52-year-old Japanese man noticed watery diarrhea, alopecia, dysgeusia, and nail atrophy ( Fig. 1 ) in October 1998 and visited a hospital. He underwent abdominal computed tomography (CT) scanning and ultrasonography, but no abnormal findings were observed. Because the symptoms persisted, and edema of the extremities also occurred, he visited our hospital, in January 1999, and was admitted in March 1999 for further examination. His family had no history of significant bowel disease. Physical examinations revealed that he had relatively poor nutrition, with loss of scalp hair, atrophy of fingernails and toenails, and edema of the extremities, while other physical examination results were unremarkable. Laboratory tests showed hypoproteinemia (total protein, 4.3 g/dl; albumin, 2.0 g/dl), and poor nutrition. Serum levels of Zn and cholinesterase (ChE) were slightly decreased, while levels of liver enzymes and creatinine were all normal. Serum carcinoembryonic antigen level was 5.5 ng/ml (normal range at our hospital, less than 5.0 ng/ml). Radiological examination revealed multiple polyps and a protruding tumor located on the posterior wall of the antrum of the stomach (Fig. 2) , while a barium enema also showed multiple polyps, from the transverse colon to the rectum. Gastrofiberscopy and colonofiberscopy confirmed the presence of polyps. While colon polyps are a typical feature of Cronkhite-Canada syndrome and have been shown by histology to be benign, the histological findings of the biopsied specimens from the antrum revealed the protruding tumor to be an adenocarcinoma.
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The patient was diagnosed as having CronkhiteCanada syndrome with gastric cancer, and a laparotomy was performed on April 20, 1999 . The stomach, small intestine, and colon were edematous; this was probably caused by the hypoproteinemia. Total gastrectomy combined with lymph node dissection (D2) was
Introduction
In 1955, Cronkhite and Canada [1] reported two cases of patients that suffered from generalized gastrointestinal polyps associated with pigmentation of the skin, alopecia, and atrophy of the finger nails and toenails. Following this initial description, a number of similar cases have since been reported. Although Cronkhite-Canada syndrome is generally accepted to be a benign disorder, we report a case of this syndrome in a patient in whom gastric carcinoma, combined with multiple gastric polyps, was diagnosed.
Offprint requests to: T. Egawa Received: July 24, 2000 / Accepted: September 18, 2000 performed. About 1000 ml of serous bloody fluid was discharged during the operation; however, the cancer invasion was histologically limited to the muscularis propria, with no evidence of lymph node metastasis. The surgical specimen revealed diffuse multiple polyps associated with type 1 tumor (according to the Japanese classification of gastric carcinoma of the Japanese Research Society for Gastric Cancer [2] ) located on the posterior wall of the gastric antrum (Fig. 3) .
After the operation, the patient had an uneventful course and recovered from the hypoproteinemia, alopecia, and nail atrophy.
Pathological findings
Surgical specimens were fixed in 10% formalin and embedded in paraffin. Sections of the paraffinembedded specimens were stained with hematoxylineosin (H&E) and showed typical features of Cronkhite-Canada syndrome, including massive submucosal edema, mild infiltration of inflammatory cells, hyperplasia of the foveolar epithelium, and cystic dilatation of the mucosal glands (Fig. 4a,b ). Cancer nests, predominantly consisting of poorly differentiated adenocarcinoma cells combined with partly tubular formations of cancer cells, were observed; however, no adenomatous changes were observed around the cancer nests, suggesting that the cancer originated directly from the gastric mucosa. This idea was also validated by Ki-67 ( Fig. 5a ) and p53 ( Fig. 5b ) staining, in which only cancer cells were stained with Ki-67 and p53, indicating that only the cancer cells had proliferative activity and that there was mutated p53 protein without intermediate changes between the surrounding mucosa and cancer nests. Although cancer tissue infiltration, up to the muscularis propria, and lymphatic invasion were observed, no lymph node metastases were observed in 28 resected regional lymph nodes. After resection of the jejunal mucosa during the Roux-en-Y anastomosis, H&E-stained jejunal mucosa specimens showed mild hyperplasia of the foveolar epithelium, mild edema of intestinal tissue, and chronic infiltration of inflammatory cells. However, these changes were slight compared with the changes observed in the gastric mucosa.
Discussion
Cronkhite-Canada syndrome was first reported in 1955 as generalized gastrointestinal polyposis with ecto- dermal changes consisting of alopecia, hyperpigmentation, and onychodystrophy [1] . The major presenting symptom is watery diarrhea, frequently associated with dysgeusia, anorexia, weight loss, and peripheral edema caused by hypoproteinemia [3] . Although polyps are present throughout the gastrointestinal tract in Cronkhite-Canada syndrome, esophageal polyps are very rare, probably because of their squamous cell origin. In their original report, Cronkhite and Canada considered the polyps to be adenomatous. However, recent reports have shown that the polyps contain cystically dilated glands without cellular atypia and resemble juvenile-type polyps, suggesting that the polyps may be non-neoplastic in nature [4] . Malignant transformation of Cronkhite-Canada syndromeassociated polyps is considered extremely rare and coincidental. Of the increasing numbers of reports of this syndrome, those that note an association with carcinoma in the gastrointestinal tract refer to the colon. Up to the end of 1998, 374 cases of this syndrome had been reported in the world literature. Gastric cancer associated with Cronkhite-Canada syndrome was first described by Nakamura et al. [5] in 1979, and the 19 reported cases of Cronkhite-Canada syndrome occurring with gastric cancer (including the present case) are shown in Table 1 .
The association rate between Cronkhite-Canada syndrome and gastric cancer is 5.1% (19/374), with the 19 patients consisting of 15 men and 4 women, ranging in age from 46 to 78 years (mean age, 64.2 years), with all patients originating from Japan. The mortality rate of gastric cancer in Japan has been reported to be approximately 100 per 100 000 population for the past 20 years [23] . Although the true incidence of gastric cancer is not correctly recognized, it is estimated to be 0.2%, or 200 persons per 100 000 population, with the mortality rate after surgery assumed to be 50%. If this were the case, the 5.1% incidence of gastric cancer associated with Cronkhite-Canada syndrome suggests there may be a high-risk condition for stomach malignancy in patients with this syndrome, although the very large difference in population numbers prevents a precise correlation between these two cohorts. The histological types of the associated polyps in the 19 patients were: juvenile-type (n ϭ 13) and adenoma coexisting with juvenile-type polyps (n ϭ 6). Six reported patients with Cronkhite-Canada syndrome associated with gastric cancer showed adenoma and adenomatous changes around the cancer, suggesting the adenoma-carcinoma sequence in their carcinogenesis. However, in the present patient, only the cancer cells were stained with Ki-67 and p53, without any intermediate changes shown between the cancer nests and the surrounding mucosa, indicating that only the cancer cells had proliferative activity with mutated p53 protein.
From these findings, it is likely that the etiology of gastric cancer in the present patient was coincidental. In the reported patients, the depth of invasion was histologically limited to the mucosa in 9, to the submucosa in 2, to the muscularis propria in 1, to the subserosa in 6, and was unknown in 1 patient.
Of the reported patients with Cronkhite-Canada syndrome associated with colorectal cancer, 41% (14/ 34) showed association with adenoma or adenomatous change. In some of the reported patients, adenomatous proliferation was seen in the epithelium at the tips of the juvenile-type polyps, and a clear transition to adenomatous proliferation and carcinogenic transformation was demonstrated. In addition, expression of mutant p53 protein was confirmed in parts of the adenomatous and carcinomatous areas, but not in the juvenile-type polyps [24] . In some colorectal cancers, the adenomacarcinoma sequence has been established as the carcinogenesis, and the reported adenomatous changes around gastric cancer nests in the patients with Cronkhite-Canada syndrome suggests that some gastric cancers in this syndrome may be related to the adenoma-carcinoma sequence, while other gastric cancers will have arisen coincidentally, as shown in the present patient. The etiology of gastric cancer in Cronkhite-Canada syndrome is controversial, regarding whether it is related to the adenoma-carcinoma sequence shown in colon cancer or whether it is coincidental (de novo). However, as all the reported patients with the Cronkhite-Canada syndrome associated with gastric cancer, including the present patient, had juvenile-type polyps, with only 6 of the 19 patients also showing adenoma, it is likely that the etiology of gastric cancer in the present patient may be coincidental.
Our patient with Cronkhite-Canada syndrome associated with gastric cancer was treated with total gastrectomy, as the remnant stomach may have retained malignant potential and the edematous mucosa could have led to anastomotic leakage because of the abnormal conditions. As one of the important reasons for Cronkhite-Canada syndrome having a poor prognosis is the malnutrition resulting from altered absorption in the gastrointestinal tract, it is also necessary to control protein loss. While a few patients have been successfully treated with enteral nutrition, steroids, and antiplasmin therapy [25] [26] [27] , we, nevertheless, recommended surgery, as total gastrectomy also prevented protein loss [28] . General reasons for recommending total gastrectomy for patients with Cronkhite-Canada syndrome associated with gastric cancer are: (1) to obviate the malignant potential of the remnant stomach, (2) to reduce the high risk of anastomotic leakage caused by gastrointestinal edema, and (3) to prevent protein loss from the stomach. Reason (1) was appropriate in the present patient, as shown by the histological results, but this information was not obtained before or during the operation.
In conclusion, we suggest that patients with Cronkhite-Canada syndrome should be carefully screened, particularly for the stomach, colon, and rectum, so that the appropriate surgical therapy can be used to improve their survival outcome.
